Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasm Malignant Female × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Polycystic Ovary Syndrome 6 Infertility 4 Neoplasm Metastasis 2 Leiomyoma 2 is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1 Patient Acceptance of Health Care 1 Ovarian Cysts 1 Myofibroma 1 Locally Advanced Breast Cancer 1 Infertility, Female 1 Carcinoma, Ductal 1 Breast Neoplasm Malignant Female 1 Breast Carcinoma In Situ 1 Anovulation 1 Abortion, Spontaneous 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04289805 2025-01-31

fAMHOPE

Erasme University Hospital

Phase 4 Terminated

Breast Neoplasm Malignant Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡